Drug
Setrusumab
Setrusumab: highest development phase Phase 3, developed by Ultragenyx Pharmaceutical. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Ultragenyx Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Setrusumab NCT05768854 | Phase 3 | Osteogenesis Imperfecta |
| setrusumab NCT06636071 | Phase 3 | Osteogenesis Imperfecta |
| Setrusumab NCT05125809 | Phase 2/3 | Osteogenesis Imperfecta |
Latest
No recent events.
Follow Setrusumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.